Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections.
Cohen
Philip R
PR
University of Houston Health Center, Department of Dermatology, USA. mitehead@aol.com
Grossman
Marc E
ME
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology; D004196:Disease Outbreaks; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D012307:Risk Factors; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects; D014481:United States / Q000453:epidemiology; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D014640:Vancomycin